课题基金 / 基金详情

YY2因子在肿瘤细胞染色体不稳定性调控中的生物学机制研究

批准号:
32070715
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
江启慧
依托单位:
学科分类:
细胞增殖及细胞周期
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
江启慧

项目摘要

结项摘要

江启慧的其他基金

相似基金

相关文献

中文摘要
染色体不稳定性(CIN)作为肿瘤的基本特征之一,在肿瘤发生发展中具有重要作用。适当水平CIN(M-CIN)能促进肿瘤发生发展,然而过高水平的CIN(H-CIN)则能诱导肿瘤细胞死亡。YY2是阴阳因子家族的成员,与其同源因子YY1相反,YY2能抑制肿瘤细胞的增殖,但有关其生物功能的报道尚少。项目前期实验发现YY2能导致肿瘤细胞有丝分裂异常,诱发过高水平CIN的产生。然而,YY2诱发H-CIN的分子机制及其诱发H-CIN对肿瘤细胞命运调控的影响尚未清楚。本项目拟从以下三方面展开研究:(1) 阐明YY2对肿瘤细胞有丝分裂异常及H-CIN水平的作用机制;(2) 揭示YY2通过诱导H-CIN影响肿瘤细胞命运的分子调控机制;(3) 阐明YY2通过诱导H-CIN影响肿瘤发生发展以及耐药性的作用机制。本项目不仅阐明YY2诱发肿瘤细胞H-CIN产生的新生物学机制,同时也为临床肿瘤治疗干预策略提供新的思路。
英文摘要
Chromosomal instability (CIN) is defined as a persistently high rate of loss and gain of whole or part of chromosomes that results in the aberrant chromosome structure and number. Chromosomal instability is one of the hallmarks of tumor that plays a crucial role in tumorigenesis. Previous researches have revealed that moderate level of chromosomal instability (M-CIN) benefits tumor progression as it increases tumor heterogeneity, thus enables tumor cells to be more adaptive upon exposure to tumor microenvironment stress. Furthermore, M-CIN also increases tumor cells resistance to anti-tumor drugs. However, recent studies reported that aberrantly high CIN could induce tumor cells death. Excessive high-level CIN (H-CIN) induces genetic catastrophe, and thus eventually inhibits tumor progression.. Yin Yang 2 (YY2) is a member of Yin Yang family which originates from and shares a high homology with Yin Yang 1 (YY1). However, in contrast with YY1 which is an oncogene, recent studies showed that YY2 could suppress tumor cell proliferation. Despite its function as a tumor suppressor gene, our knowledge regarding the biological function of YY2 is still very limited. Our pilot experiments showed that YY2 overexpression suppressed the increase of colorectal carcinoma cell number as well as the expression levels of M phase regulatory proteins, indicating that YY2 overexpression inhibits cell cycle, especially M phase, progression. Furthermore, we found that YY2 overexpression elevated the number of mitotic errors, including monopolar spindle, multipolar spindle and chromosome bridge; all of which could result in chromosome structural and numeral abnormity. . We also found significant increases in the number of cells with more than 46 chromosomes, heteroploidy cells, as well as the number of micronucleus, which could increase tumor progression and metastasis, in YY2-overexpressed colorectal carcinoma cells. YY2 overexpression also promoted DNA damage. As aberrant chromosome number, heteroploidy, as well as increased micronucleus number and DNA damage are indicator of increased CIN level, these findings suggest that YY2 induces high level CIN. YY2 overexpression also induced cell death, as well as alteration of the expression of genes related to mitotic control and CIN. However, the molecular mechanism of YY2 regulation on mitosis progression and CIN, as well as its role in determining tumor cell fate remains unraveled.. In this study, we hypothesize that YY2 is involved in mitotic regulation and induction of H-CIN, and eventually plays a critical role in determining tumor cells fate as well as tumorigenesis. Thus, we aim to: (1) unravel the effect and molecular mechanism of YY2 on tumor cell mitotic error and the induction of H-CIN; (2) elucidate the regulatory mechanism of YY2-induced H-CIN on tumor cell fate, including cell proliferation and cell death; (3) reveal the effect and molecular mechanism of YY2-induced H-CIN on tumorigenesis and on suppressing tumor drug resistance. This study will not only unravel the novel molecular mechanism of YY2 regulation on tumorigenesis, but also will provide experimental evidences for the development of new combinatorial anti-tumor therapeutic strategy based on YY2 overexpression and anti-tumor drugs.
纺锤体组装检查点(SAC)是确保姊妹染色体正确分离和有丝分裂进程的细胞周期检查点,其紊乱常常导致染色体错误分离并诱发染色体不稳定性(Chromosomal Instability, CIN),即染色体结构和数量的异常。虽然CIN通常与发育缺陷等异常相关,却同时也是肿瘤的重要特征。目前研究表明约90%的肿瘤细胞中都呈现出CIN,且CIN促进肿瘤的发生发展;然而,近年临床研究发现具有高水平CIN的肿瘤患者则具有更好的预后效果。这些矛盾导致前期研究提出了肿瘤细胞CIN“恰到好处”的模型,即适当水平CIN(M-CIN)有利于肿瘤发生发展,而过高水平CIN(H-CIN)则起到相反的作用。然而,有关H-CIN对肿瘤细胞命运的报道较少,CIN“恰到好处”模型尚缺乏充足的实验证据,CIN对肿瘤细胞命运和临床治疗反应的影响尚未清楚。. 本项目研究筛选发现SAC的新调控因子YY2,并揭示了过表达YY2通过促进BUB3转录增强SAC活性,延长有丝分裂时长,诱发H-CIN从而促进肿瘤细胞死亡。本项目还发现敲除YY2虽然也诱发CIN,却导致SAC活性降低、缩短有丝分裂时长、促进肿瘤细胞增殖;然而进一步降低YY2敲除的肿瘤细胞SAC活性则导致肿瘤细胞CIN进一步升高并诱发细胞死亡。这些研究结果提示了M-CIN有利于肿瘤细胞,但无论是SAC过活化还是异常降低导致的高水平CIN(H-CIN)则都能诱发细胞死亡。 . 本项目同时还阐明了H-CIN与肿瘤耐药之间的关系,研究发现具有H-CIN的肿瘤细胞更容易死亡;同时发现残留肿瘤细胞具有适当水平CIN(M-CIN)。本项目通过细胞和动物实验等方法证明了利用过表达YY2诱发H-CIN与DNA损伤药物合用起到肿瘤治疗协同作用,显著提高肿瘤细胞的抗肿瘤药物敏感性。. 综上所述,本项目不仅阐明了转录因子YY2通过调控SAC活性起到抑癌作用的新机制,同时也阐明了利于肿瘤细胞生存的CIN“恰到好处”模型。本项目也提出了CIN诱导剂与DNA损伤诱导剂的联合将成为潜在的抗肿瘤治疗新策略。
锌指蛋白YY2通过调控纺锤体组装检查点促进肿瘤细胞焦亡的作用机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    江启慧
  • 依托单位:
锌指蛋白p52-ZER6通过调控线粒体自噬维持肿瘤干细胞干性的机制研究
  • 批准号:
    --
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2022
  • 负责人:
    江启慧
  • 依托单位:
锌指蛋白ZER6/p21信号通路在细胞周期调控中的作用机制研究
  • 批准号:
    31871367
  • 项目类别:
    面上项目
  • 资助金额:
    59.0万元
  • 批准年份:
    2018
  • 负责人:
    江启慧
  • 依托单位:
信号通路XBP1-p21在细胞周期调控中的分子机制研究
  • 批准号:
    31301119
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2013
  • 负责人:
    江启慧
  • 依托单位:
国内基金
海外基金